Time to detection of Mycobacterium tuberculosis in sputum culture correlates with outcome in patients receiving treatment for pulmonary tuberculosis.
about
Serial counts of Mycobacterium tuberculosis in sputum as surrogate markers of the sterilising activity of rifampicin and pyrazinamide in treating pulmonary tuberculosisInhaled nitric oxide treatment of patients with pulmonary tuberculosis evidenced by positive sputum smears.Time to detection of Mycobacterium tuberculosis as an alternative to quantitative cultures.Drug tolerance in Mycobacterium tuberculosis.Culture conversion rate at 2 months of treatment according to diagnostic methods among patients with culture-positive pulmonary tuberculosis.Evaluation of time to detection of Mycobacterium tuberculosis in broth culture as a determinant for end points in treatment trials.Tuberculosis and illicit drug use: review and update.Active and latent tuberculosis among HIV-positive injecting drug users in IndonesiaUrine lipoarabinomannan to monitor antituberculosis therapy response and predict mortality in an HIV-endemic region: a prospective cohort study.Factors influencing sputum smear conversion at one and two months of tuberculosis treatment.Bacterial Loads Measured by the Xpert MTB/RIF Assay as Markers of Culture Conversion and Bacteriological Cure in Pulmonary TB.Cavitary disease and quantitative sputum bacillary load in cases of pulmonary tuberculosis.Tuberculous Pericarditis is Multibacillary and Bacterial Burden Drives High MortalityPredicting the outcome of therapy for pulmonary tuberculosis.Delay in diagnosis of pulmonary tuberculosis at a primary health clinic in Vitoria, Brazil.A Faropenem, Linezolid, and Moxifloxacin Regimen for Both Drug-Susceptible and Multidrug-Resistant Tuberculosis in Children: FLAME Path on the Milky Way.Shortening treatment in adults with noncavitary tuberculosis and 2-month culture conversion.Time to detection of Mycobacterium tuberculosis using the MGIT 320 system correlates with colony counting in preclinical testing of new vaccines.The burden of HIV on Tuberculosis patients in the Volta region of Ghana from 2012 to 2015: implication for Tuberculosis control.Monitoring treatment of patients with pulmonary tuberculosis: can PCR be applied?Ceftazidime-avibactam has potent sterilizing activity against highly drug-resistant tuberculosis.Suitability of Xpert MTB/RIF and genotype MTBDRplus for patient selection for a tuberculosis clinical trial.Sputum volume predicts sputum mycobacterial load during the first 2 weeks of antituberculosis treatment.Relative versus absolute noncontagiousness of respiratory tuberculosis on treatment.Measurement of sputum Mycobacterium tuberculosis messenger RNA as a surrogate for response to chemotherapy.Modelling of mycobacterial load reveals bedaquiline's exposure-response relationship in patients with drug-resistant TB.Correlation of Xpert MTB/RIF with measures to assess Mycobacterium tuberculosis bacillary burden in high HIV burden areas of Southern Africa.Factors Associated with Persistent Sputum Positivity at the End of the Second Month of Tuberculosis Treatment in Lithuania.
P2860
Q24796366-9EFFDB42-03B6-4345-9215-F011244D7EA1Q33858205-53FC8A46-4194-4A3F-8295-E398B899FA58Q33941934-B4EACECD-CB2C-47DF-8F48-FBE26C8037EDQ33977977-06A4342E-C95A-45BA-9C3D-6FF04A4C7AF7Q34020372-F5DFE4B3-CB54-4177-A061-658E0EEDF8D9Q34433240-FFF49F58-69F7-4C7E-9F04-7A36A6EAFD6BQ34601143-58AF2823-9FBE-42D4-BE5F-C66781911338Q35091998-971A00B4-C453-4F7C-B1FC-DAF39E9E8D77Q35466103-63790475-6A94-49FA-9DE4-FC37C847704DQ35740869-D1DF5754-7C29-4B2D-B60D-8A14FD2A4050Q36100081-CFB50072-2FC7-4686-A2CF-B3A6B6008487Q36314493-843CC01E-2E74-4B02-871B-372781A32B0FQ36540925-7FCBB2B7-8B6C-4C35-B995-B8AA4E91B209Q36576104-D469A0B5-C4D5-45E6-9C99-7EAA7309B4A5Q36972051-7FC6ACB0-4564-4C75-9F7C-E2AB3777304AQ37339279-05082306-B640-48D9-B53D-0DA42348E721Q37343752-21079660-7041-4A45-A0D5-B3B264B81D55Q38320793-E9C9A591-67F6-43A2-8532-28430AD72593Q39445754-85BEB905-F428-4526-9541-CCFC95D8E90AQ39453133-F5BBF19D-CA8D-48DC-B7C0-AD0B6B6CA427Q40065397-9BD74F08-BFF0-443D-9166-163A59A10FFAQ41771157-41A1DDF5-15B7-453B-8858-88C06B471639Q41899058-845F337D-6B63-43AF-8C35-A650D9D5B006Q44676329-C569F052-A9BE-45DB-BA36-5F5882809D23Q47328162-12358C3A-7F7F-45F5-B072-E862B907CCB8Q47898423-2D20A7F3-53D3-42FC-81D4-BCDB12CA477AQ54957532-510CDF4B-0604-41EE-8588-AD241993EC35Q55518558-A89D18B8-46D0-4F66-8C60-7E451D3C3DFC
P2860
Time to detection of Mycobacterium tuberculosis in sputum culture correlates with outcome in patients receiving treatment for pulmonary tuberculosis.
description
1998 nî lūn-bûn
@nan
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
1998年论文
@zh
1998年论文
@zh-cn
name
Time to detection of Mycobacte ...... nt for pulmonary tuberculosis.
@en
type
label
Time to detection of Mycobacte ...... nt for pulmonary tuberculosis.
@en
prefLabel
Time to detection of Mycobacte ...... nt for pulmonary tuberculosis.
@en
P2093
P921
P356
P1433
P1476
Time to detection of Mycobacte ...... nt for pulmonary tuberculosis.
@en
P2093
P304
P356
10.1378/CHEST.113.2.379
P407
P577
1998-02-01T00:00:00Z